 |
|
Cost-Conscious Prescribing of Nonsteroidal Anti-inflammatory Drugs for Adults With ArthritisA Review and Suggestions
Jerry M. Greene, MD;
Richard N. Winickoff, MD
Arch Intern Med. 1992;152(10):1995-2002.
Abstract
| |
Salicylates and nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for the treatment of painful disorders. This article reviews the efficacy, side effects, and costs of these agents and proposes a practical approach to using them in a cost-effective manner. Although there may be some differences in efficacy among available drugs, these do not appear sufficient to justify using the more expensive agents in most cases. Adverse effects, especially gastrointestinal (GI), add to the cost of using these drugs. Aspirin and all nonsalicylate NSAIDs share a risk of causing gastric ulcer, upper GI bleeding, and GI perforation. Prostaglandin inhibition by these agents may lead to reduced glomerular filtration rate and renal failure. There may be modest differences in GI and renal risks with the different agents, but these are minimal. Prophylaxis against gastric ulceration with anti-ulcer drugs has been recommended, and one agent, misoprostol, is approved for use in the United States for this purpose. Whether use of prophylaxis will increase or decrease the costs associated with NSAID therapy remains to be determined. Nonacetylated salicylates may cause less GI adverse effects and may be somewhat "renal sparing." Strategies that would reduce the cost of care for painful musculoskeletal disorders without compromising quality of care include using acetaminophen instead of an NSAID for noninflammatory disorders, trying nonacetylated salicylates as less expensive and safer alternatives to NSAIDs, using one agent at a time, allowing sufficient time to evaluate the therapeutic effect before changing agents, returning to the least expensive and/or safest drug if a trial of several in succession fails to find one that is clearly better, and reserving prophylactic use of antiulcer agents for patients who are at especially high risk and for whom anti-inflammatory effects are clearly needed.
(Arch Intern Med. 1992;152:1995-2002)
Author Affiliations
From the Department of Medicine, Harvard Medical School, and the Department of Veterans Affairs, Brockton/West Roxbury (Mass) Medical Center.
Footnotes
Accepted for publication March 24, 1992.
The views expressed are those of the authors and do not represent positions or policies of the US Department of Veterans Affairs.
Reprint requests to 11-A, West Roxbury Veterans Affairs Medical Center, 1400 VFW Parkway, West Roxbury, MA 02132 (Dr Greene).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Variable Effects of Nonsteroidal Antiinflammatory Agents on Thyroid Test Results
Samuels et al.
J. Clin. Endocrinol. Metab. 2003;88:5710-5716.
ABSTRACT
| FULL TEXT
Aspirin Does Not Increase Bleeding Complications After Transbronchial Biopsy
Herth et al.
Chest 2002;122:1461-1464.
ABSTRACT
| FULL TEXT
Process of Care and Outcomes for Elderly Patients Hospitalized With Peptic Ulcer Disease: Results From a Quality Improvement Project
Brock et al.
JAMA 2001;286:1985-1993.
ABSTRACT
| FULL TEXT
Systematic review of the cost effectiveness of prophylactic treatments in the prevention of gastropathy in patients with rheumatoid arthritis or osteoarthritis taking non-steroidal anti-inflammatory drugs
van Dieten et al.
Ann Rheum Dis 2000;59:753-759.
ABSTRACT
| FULL TEXT
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
Wolfe et al.
NEJM 1999;340:1888-1899.
FULL TEXT
Cost-effectiveness of the Arthritis Self-Help Course
Kruger et al.
Arch Intern Med 1998;158:1245-1249.
ABSTRACT
| FULL TEXT
Cost Savings Using a Stepped-Care Prescribing Protocol for Nonsteroidal Anti-inflammatory Drugs
Jones et al.
JAMA 1996;275:926-930.
ABSTRACT
Is Misoprostol Cost-effective in the Prevention of Nonsteroidal Anti-inflammatory Drug--Induced Gastropathy in Patients With Chronic Arthritis? A Review of Conflicting Economic Evaluations
Stucki et al.
Arch Intern Med 1994;154:2020-2025.
ABSTRACT
|
